JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lotze, U.
Right arrow Articles by Figulla, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lotze, U.
Right arrow Articles by Figulla, H. R.

Recovery of the Cardiac Adrenergic Nervous System After Long-Term ß-Blocker Therapy in Idiopathic Dilated Cardiomyopathy: Assessment by Increase in Myocardial 123I-Metaiodobenzylguanidine Uptake

Ulrich Lotze, Stefan Kaepplinger, Andreas Kober, Barbara M. Richartz, Dietmar Gottschild and Hans R. Figulla

Department of Internal Medicine III (Cardiology, Angiology, and Intensive Care Medicine) and Department of Nuclear Medicine, Friedrich-Schiller-University, Jena, Germany



View larger version (95K):

[in a new window]
 
FIGURE 1. 123I-MIBG images obtained from short-axis reconstruction in patient with IDC. The M/C ratio reflecting myocardial 123I-MIBG uptake increased from 2.4 before treatment to 3.6 after treatment with ß-blocker (bisoprolol) for about 1 y. C = left ventricular cavity; M = myocardium.

 


View larger version (22K):

[in a new window]
 
FIGURE 2. Changes in 123I-MIBG M/C ratio (A), LVEF (B), LVEDD (C), and New York Heart Association (NYHA) functional class (D) under ß-blocker therapy for 1 y. Individual data points for each patient and mean values ± SD of four parameters measured at entry and after 1 y of treatment with ß-blockers are shown.

 


View larger version (16K):

[in a new window]
 
FIGURE 3. Individual course of LVEF and M/C ratio of patients shows good relationship between changes in LVEF (LVEF at follow-up examination - LVEF at baseline) and 123I-MIBG M/C ratio after 1 y of therapy with ß-blockers. In one patient (*), LVEF remained unchanged at 40%, and M/C ratio only increased from 3.12 to 3.18. In another patient (**), LVEF showed small decrease in LVEF from 35% to 30% and in M/C ratio from 2.26 to 2.17. In the remaining eight patients, ascending lines indicate simultaneous increase in LVEF and in M/C ratio.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.